ArticlePloS one2026

A first-in-human, phase I/IIa trial of the T cell immunotherapy personalised tumour trained lymphocytes in patients with advanced colorectal cancer: Study protocol.

Ahmed Tarfy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.